Viewing Study NCT03205306



Ignite Creation Date: 2024-05-06 @ 10:15 AM
Last Modification Date: 2024-10-26 @ 12:27 PM
Study NCT ID: NCT03205306
Status: COMPLETED
Last Update Posted: 2023-01-10
First Post: 2017-06-08

Brief Title: Myasthenia Gravis and Psyche
Sponsor: Charite University Berlin Germany
Organization: Charite University Berlin Germany

Study Overview

Official Title: Myasthenia Gravis and Psyche
Status: COMPLETED
Status Verified Date: 2023-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to systematically capture and characterize mental comorbidities for patients with myasthenia gravis Anxiety disorders and depression for example can negatively affect the quality of life and lead to eg unemployment and early retirement especially in young patients

Additionally the researchers want to find out in what way certain aspects of the disease have an influence on the quality of life and whether different concepts of coping with the disease have different effects on the quality of life for patients with myasthenia gravis

During the study close relatives of patients will also be asked to provide input about their current stress situation in the context of supporting their relative

Based on the results the investigators want to improve and supplement established treatment concepts to ensure a more comprehensive and individual treatment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None